Relief Therapeutics Holding SA / Key word(s): Patent27-Apr-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key.
Relief Therapeutics Holding SA / Key word(s): Patent Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE(R) 27-Apr-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR.
Relief Therapeutics Holding SA / Key word(s): Study results28-March-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports In Vivo Data Publis.
Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Reports In Vivo Data Indicating Prolonged Release of Amino Acids Using Its Physiomimic Technology May Have Benefits for